$SYM

KANE CHARLES sold $92K of SYM

KANE CHARLES sold 2,000 shares of Symbotic Inc. (SYM) at $45.99 on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · KANE CHARLES
Published Jun 3, 2026, 11:12 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 3, 2026, 11:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SYM
Neutral
medium confidence
Mentioned
$SYM
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SYMNeutralLow
01

Why it matters

The disclosure provides incremental sentiment information but is typically discounted when tied to 10b5-1 plans; absent other news, it is unlikely to drive a durable repricing.

02

Market read

A routine 10b5-1 director sale in SYM, with limited expected impact unless part of a broader pattern.

03

What to watch

Traders may over-weight the sale; the key is whether there are repeated, non-10b5-1 sales or concurrent fundamental disclosures (not present here).

Relevance 6/10Novelty 3/10Timing: Filed 2026-06-03; sale executed 2026-06-01.

Background

This is an SEC Form 4 insider transaction disclosure (director selling shares) for Symbotic, executed under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$SYMNeutralMedium confidence
Context

Director Kane Charles sold 2,000 Symbotic shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Limited/short-lived impact; any reaction likely fades unless accompanied by other fundamental news.

Evidence & confidence

The filing is a routine 10b5-1 sale by a director, with no accompanying operational or financial catalyst stated in the article.

Market effects

Minimal; this is company-specific insider transaction with no sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity rather than a negative view on fundamentals.

Key entities

  • Symbotic Inc.

    Public company whose director executed an open-market sale disclosed on Form 4.

  • Kane Charles

    Director who sold 2,000 shares; transaction is marked as under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SYMMed

Symbotic director Charles Kane sells $78,000 of Class A stock

Symbotic Inc. director Charles Kane sold 2,000 shares of Class A stock for $78,000 at $39 per share on September 1, 2026. The stock currently trades at $41.60, down 30% year-to-date. Symbotic reported Q3 revenue of $721 million, up 22% YoY, and adjusted EBITDA of $95 million, more than double the previous year. Despite strong results, the stock declined in after-hours trading due to concerns over future margins and outlook.

$NBISMed

3 Growth Stocks to Buy Before Wall Street Catches On

Nebius (NBIS) reported 454% revenue growth and a $37.5B backlog, with Meta and NVIDIA deals. Symbotic (SYM) trades near 52-week lows despite a $22.5B backlog. Centrus Energy (LEU) beat Q2 EPS by 93% with a $4.5B backlog. All three companies show high growth but trade below consensus targets.

$SYMMed

What’s Really Behind Symbotic’s (SYM) Big Quarter?

Symbotic Inc. (NASDAQ:SYM) reported fiscal Q3 revenue of $721M, up 22% year over year, with net income of $55M versus a $21M loss a year earlier. Adjusted EBITDA rose to $95M. The company said 11 new deployments brought totals to 77 in deployment. Shares face a high forward P/E (238.1) and 28.1% short interest.

$OUSTMed

Robotics Stocks Rally as Unitree’s 8000X Oversubscribed IPO Draws Frenzied Demand: Ouster, Symbotic, and Teradyne in Focus

Robotics and physical AI stocks rose after China’s Unitree Robotics Shanghai IPO reportedly drew 8,000x retail oversubscription. In U.S. trading, Ouster gained 7% near $45, Symbotic rose 3% to about $41, and Teradyne added 3% to about $376. Ouster reported Q2 revenue of $54.63M (+55.9% YoY) and 17,000+ sensors; Symbotic has a ~$22.5B backlog. Analysts’ consensus targets cited $58 for OUST and $450 for TER.

$SYMHigh

Symbotic Inc. (SYM): Results of Operations and Financial Condition

Symbotic Inc. (SYM) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE Symbotic Reports Third Quarter Fiscal Year 2026 Results Steve Pagliuca, Former Co-Chair of Bain Capital, Elected to Symbotic’s Board of Directors Wilmington, Massachusetts (August 5, 2026) -- Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled